Abstract
Embryonic stem (ES) cells are pluripotent cells isolated from an early embryo and grown as a cell line in tissue culture. Their discovery came from the conjunction of studies in human pathology, mouse genetics, early mouse embryo development, cell surface immunology and tissue culture. ES cells provided a crucial tool for manipulating mouse embryos to study mouse genetics, development and physiology. They have not only revolutionized experimental mammalian genetics but, with the advent of equivalent human ES cells, have now opened new vistas for regenerative medicine.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Stevens, L. C. The biology of teratomas. Adv. Morphog. 6, 1–31 (1967).
Pierce, G. B. Teratocarcinoma: model for a developmental concept of cancer. Curr. Top. Dev. Biol. 2, 223–246 (1967).
Stevens, L. C. & Little, C. C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl Acad. Sci. USA 40, 1080–1087 (1954).
Kleinsmith, L. J. & Pierce, G. B. Jr. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24, 1544–1551 (1964).
Rosenthal, M. D., Wishnow, R. M. & Sato, G. H. In vitro growth and differetiation of clonal populations of multipotential mouse clls derived from a transplantable testicular teratocarcinoma. J. Natl Cancer Inst. 44, 1001–1014 (1970).
Kahan, B. W. & Ephrussi, B. Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma. J. Natl Cancer Inst. 44, 1015–1036 (1970).
Evans, M. J. The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratocarcinoma cells. J. Embryol. Exp. Morphol. 28, 163–196 (1972).
Martin, G. R. & Evans, M. J. The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture. Cell 2, 163–172 (1974).
Martin, G. R. & Evans, M. J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl Acad. Sci. USA 72, 1441–1445 (1975).
Nicolas, J. F., Dubois, P., Jakob, H., Gaillard, J. & Jacob, F. [Mouse teratocarcinoma: differentiation in cultures of a multipotential primitive cell line (author's transl.)]. Ann. Microbiol. (Paris) 126, 3–22 (1975).
Martin, G. R. & Evans, M. J. Multiple differentiation of clonal teratoma stem cells following embryoid body formation in vitro. Cell 6, 467–474 (1975).
Rossant, J. Investigation of the determinative state of the mouse inner cell mass. II. The fate of isolated inner cell masses transferred to the oviduct. J. Embryol. Exp. Morphol. 33, 991–1001 (1975).
Evans, M. J. in Germ Cell Tumours (eds Anderson, C. J., Jones, W. G. & Milford-Ward, A.) (Taylor and Francis, London, 1981).
Gardner, R. L. Contributions of blastocyst micromanipulation to the study of mammalian development. Bioessays 20, 168–180 (1998).
Brinster, R. L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 140, 1049–1056 (1974).
Papaioannou, V. E., McBurney, M. W., Gardner, R. L. & Evans, M. J. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 258, 70–73 (1975).
Mintz, B. & Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl Acad. Sci. USA 72, 3585–3589 (1975).
Artzt, K. et al. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture. Proc. Natl Acad. Sci. USA 70, 2988–2992 (1973).
Solter, D. & Knowles, B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl Acad. Sci. USA 75, 5565–5569 (1978).
Gooi, H. C. et al. Stage-specific embryonic antigen involves α 1 goes to 3 fucosylated type 2 blood group chains. Nature 292, 156–158 (1981).
Childs, R. A. et al. High-molecular-weight glycoproteins are the major carriers of the carbohydrate differentiation antigens I, i and SSEA-1 of mouse teratocarcinoma cells. Biochem. J. 215, 491–503 (1983).
Stern, P. L., Martin, G. R. & Evans, M. J. Cell surface antigens of clonal teratocarcinoma cells at various stages of differentiation. Cell 6, 455–465 (1975).
Evans, M. J., Lovell-Badge, R. H., Stern, P. L. & Stinnakre, M. G. in INSERM Symposium 10 (ed. Douarin, N. L.) 115–129 (Elsevier, Amsterdam, 1979).
Jacob, F. Mouse teratocarcinoma and embryonic antigens. Immunol. Rev. 33, 3–32 (1977).
Adamson, E. D., Evans, M. J. & Magrane, G. G. Biochemical markers of the progress of differentiation in cloned teratocarcinoma cell lines. Eur. J. Biochem. 79, 607–615 (1977).
Stern, P. L. et al. Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell 14, 775–783 (1978).
Lovell-Badge, R. H. & Evans, M. J. Changes in protein synthesis during differentiation of embryonal carcinoma cells and a comparison with embryo cells. J. Embryol. Exp. Morph. 59, 187–206 (1980).
Stinnakre, M. G., Evans, M. J., Willison, K. R. & Stern, P. L. Expression of Forssman antigen in the post-implantation mouse embryo. J. Embryol. Exp. Morphol. 61, 117–131 (1981).
Kapadia, A., Feizi, T. & Evans, M. J. Changes in the expression and polarization of blood group I and i antigens in post-implantation embryos and teratocarcinomas of mouse associated with cell differentiation. Exp. Cell Res. 131, 185–195 (1981).
Evans, M. J. Origin of mouse embryonal carcinoma cells and the possibility of their direct isolation into tissue culture. J. Reprod. Fertil. 62, 625–631 (1981).
Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156 (1981).
Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634–7638 (1981).
Bradley, A., Evans, M., Kaufman, M. H. & Robertson, E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255–256 (1984).
Kuehn, M. R., Bradley, A., Robertson, E. J. & Evans, M. J. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326, 295–298 (1987).
Robertson, E., Bradley, A., Kuehn, M. & Evans, M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323, 445–448 (1986).
Evans, M. Embryonic stem cells: the mouse source—vehicle for mammalian genetics and beyond (Nobel lecture). Chembiochem 9, 1690–1696 (2008).
Evans, M. J., Bradley, A., Kuehn, M. R. & Robertson, E. J. The ability of EK cells to form chimeras after selection of clones in G418 and some observations on the integration of retroviral vector proviral DNA into EK cells. Cold Spring Harb. Symp. Quant. Biol. 50, 685–689 (1985).
Hooper, M., Hardy, K., Handyside, A., Hunter, S. & Monk, M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326, 292–295 (1987).
Conlon, F. L., Barth, K. S. & Robertson, E. J. A novel retrovirally induced embryonic lethal mutation in the mouse: assessment of the developmental fate of embryonic stem cells homozygous for the 413.d proviral integration. Development 111, 969–981 (1991).
Zhou, X., Sasaki, H., Lowe, L., Hogan, B. L. & Kuehn, M. R. Nodal is a novel TGF-β-like gene expressed in the mouse node during gastrulation. Nature 361, 543–547 (1993).
Evans, M. J., Carlton, M. B. L. & Russ, A. P. Gene trapping and functional genomics. Trends Genet. 13, 370–374 (1997).
Friedrich, G. & Soriano, P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5, 1513–1523 (1991).
Smithies, O. Turning pages (Nobel lecture). Chembiochem 9, 1342–1359 (2008).
Capecchi, M. R. The making of a scientist II (Nobel Lecture). Chembiochem 9, 1530–1543 (2008).
Askew, G. R., Doetschman, T. & Lingrel, J. B. Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol. Cell. Biol. 13, 4115–4124 (1993).
Clarke, A. R. Manipulating the germline: its impact on the study of carcinogenesis. Carcinogenesis 21, 435–441 (2000).
Pierce, G. B. & Dixon, F. J. Jr. Testicular teratomas. II. Teratocarcinoma as an ascitic tumor. Cancer 12, 584–589 (1959).
Pierce, G. B. Jr & Verney, E. L. An in vitro and in vivo study of differentiation in teratocarcinomas. Cancer 14, 1017–1029 (1961).
Gardner, R. L. Mouse chimeras obtained by the injection of cells into the blastocyst. Nature 220, 596–597 (1968).
Evans, M. J., Bradley, A., Kuehn, M. R. & Robertson, E. J. The ability of EK Cells to form chimeras after selection of clones in G418 and some observations on the integration of retroviral vector proviral DNA into EK cells. Cold Spring Harb. Symp. Quant. Biol. 50, 685–689 (1985).
Lovell-Badge, R. H. et al. Transformation of embryonic stem cells with the human type-II collagen gene and its expression in chimeric mice. Cold Spring Harb. Symp. Quant. Biol. 50, 707–711 (1985).
Doetschman, T. et al. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330, 576–578 (1987).
Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007).
Acknowledgements
I would like to thank my wife Judith for a lifetime of support. I would also like to acknowledge all the colleagues and students who have worked with me over the years, many of whom have gone on to remarkable careers in science and medicine. Our progress was often slow and usually enjoyable, with many memorable moments enhanced by their support. I have been supported mainly by CRC, BBSRC, MRC, SRC and the Wellcome Trust.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Evans, M.
Discovering pluripotency: 30 years of mouse embryonic stem cells. Nature Reviews Molecular Cell Biology. 12, 680–686 (2011); doi:10.1038/nrm3190
Martin Evans is a director and major shareholder of Cell Therapy, a company working in the area of cellular therapeutics. Some of the company's areas of interest are outlined in Box 2 of the article, but this is a general statement of the present position and is not specific to, or influenced by, the company's interest.
Related links
Rights and permissions
About this article
Cite this article
Evans, M. Discovering pluripotency: 30 years of mouse embryonic stem cells. Nat Rev Mol Cell Biol 12, 680–686 (2011). https://doi.org/10.1038/nrm3190
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrm3190
This article is cited by
-
Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
Molecular Psychiatry (2021)
-
Gas5 is an essential lncRNA regulator for self-renewal and pluripotency of mouse embryonic stem cells and induced pluripotent stem cells
Stem Cell Research & Therapy (2018)
-
Identification of Potential Molecular Determinants of Murine Embryonic Stem Cell Differentiation by a Transposon-Based Approach
Molecular Biotechnology (2018)
-
Modeling of Autism Using Organoid Technology
Molecular Neurobiology (2017)
-
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells
Cell Death & Differentiation (2017)